ALDER BIOPHARMACEUTICALS INC Insider Trading for June 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALDER BIOPHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALDER BIOPHARMACEUTICALS INC for June 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15 2018 | ALDR | ALDER BIOPHARMACEU ... | Azelby Robert | President and CEO | Option Exercise | A | 16.20 | 1,000,000 | 16,200,000 | 1,000,000 | |
| Jun 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 3.47 | 2,272 | 7,872 | 93,182 | |
| Jun 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 4.46 | 22,727 | 101,249 | 0 | |
| Jun 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 18.25 | 4,799 | 87,562 | 243,693 | 248.5 K to 243.7 K (-1.93 %) |
| Jun 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 17.76 | 20,200 | 358,794 | 248,492 | 268.7 K to 248.5 K (-7.52 %) |
| Jun 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 3.47 | 2,272 | 7,872 | 268,692 | 266.4 K to 268.7 K (+0.85 %) |
| Jun 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 4.46 | 22,727 | 101,249 | 266,420 | 243.7 K to 266.4 K (+9.33 %) |
| Jun 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Option Exercise | M | 0.99 | 5,040 | 4,990 | 30,244 | |
| Jun 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Option Exercise | M | 1.65 | 7,121 | 11,750 | 7,121 | |
| Jun 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Sell | S | 18.29 | 1,100 | 20,115 | 831 | 1.9 K to 831 (-56.97 %) |
| Jun 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Sell | S | 17.81 | 11,061 | 197,012 | 1,931 | 13 K to 1.9 K (-85.14 %) |
| Jun 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Buy | M | 0.99 | 5,040 | 4,990 | 12,992 | 8 K to 13 K (+63.38 %) |
| Jun 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Buy | M | 1.65 | 7,121 | 11,750 | 7,952 | 831 to 8 K (+856.92 %) |
| Jun 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Option Exercise | M | 0.99 | 22,727 | 22,500 | 0 | |
| Jun 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Sell | S | 18.24 | 4,474 | 81,587 | 102,189 | 106.7 K to 102.2 K (-4.19 %) |
| Jun 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Sell | S | 17.74 | 18,253 | 323,825 | 106,663 | 124.9 K to 106.7 K (-14.61 %) |
| Jun 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Buy | M | 0.99 | 22,727 | 22,500 | 124,916 | 102.2 K to 124.9 K (+22.24 %) |